Literature DB >> 22228884

Determination of ammonia concentrations in cirrhosis patients-still confusing after all these years?

Claudia Isabel Blanco Vela1, Francisco Javier Bosques Padilla.   

Abstract

By the end of the nineteenth century, ammonia had been identified as the main factor responsible for hepatic encephalopathy syndrome. Ammonia is one of the principal products of hepatic metabolism and high concentrations are toxic to the body. Under physiological conditions, the main way by which the body restricts the blood concentration of ammonia to a nontoxic level is by converting it to urea in the liver via the Krebs cycle. The synthesis of glutamine represents an alternative pathway for ammonia detoxification in cirrhotic patients. Although high concentrations of ammonia have been strongly associated with brain edema, estimates of the strength of the correlation between serum ammonia levels and the severity of hepatic encephalopathy vary. The accuracy of ammonia assays depends on the site of specimen collection, treatment of the specimen and the analytical method used. New methods involving measurement of the partial pressure of ammonia and new noninvasive techniques involving quantification of ammonium in the breath have been described. The purpose of this review is to identify factors that affect serum ammonia levels, from its origin and metabolism to its analysis and interpretation of results in the laboratory. In conclusion, variations in estimates of serum ammonia level and the severity of hepatic encephalopathy arise because of individual differences in ammonia metabolism and differences in the accuracy of analytical methods.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22228884

Source DB:  PubMed          Journal:  Ann Hepatol        ISSN: 1665-2681            Impact factor:   2.400


  15 in total

1.  Clinical utility of breath ammonia for evaluation of ammonia physiology in healthy and cirrhotic adults.

Authors:  Lisa A Spacek; Matthew Mudalel; Frank Tittel; Terence H Risby; Steven F Solga
Journal:  J Breath Res       Date:  2015-12-14       Impact factor: 3.262

2.  Fast and accurate exhaled breath ammonia measurement.

Authors:  Steven F Solga; Matthew L Mudalel; Lisa A Spacek; Terence H Risby
Journal:  J Vis Exp       Date:  2014-06-11       Impact factor: 1.355

Review 3.  Mental status changes postchemoembolization: the role of inflammatory response.

Authors:  Daniel Wells; Joseph Alisky; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2013-06       Impact factor: 1.513

4.  Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis.

Authors:  Harry D Zacharias; Antony P Zacharias; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2019-06-17

Review 5.  Serum Ammonia in Cirrhosis: Clinical Impact of Hyperammonemia, Utility of Testing, and National Testing Trends.

Authors:  Sasha Deutsch-Link; Andrew M Moon; Yue Jiang; A Sidney Barritt; Elliot B Tapper
Journal:  Clin Ther       Date:  2022-02-04       Impact factor: 3.637

Review 6.  Breath volatile organic compounds for the gut-fatty liver axis: promise, peril, and path forward.

Authors:  Steven Francis Solga
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

7.  Polyethylene Glycol and Lactulose versus Lactulose Alone in the Treatment of Hepatic Encephalopathy in Patients with Cirrhosis: A Non-Inferiority Randomized Controlled Trial.

Authors:  Mohammadreza Naderian; Heshmatollah Akbari; Morteza Saeedi; Amir Ali Sohrabpour
Journal:  Middle East J Dig Dis       Date:  2017-01

Review 8.  A model of blood-ammonia homeostasis based on a quantitative analysis of nitrogen metabolism in the multiple organs involved in the production, catabolism, and excretion of ammonia in humans.

Authors:  David G Levitt; Michael D Levitt
Journal:  Clin Exp Gastroenterol       Date:  2018-05-24

Review 9.  L-ornithine L-aspartate for prevention and treatment of hepatic encephalopathy in people with cirrhosis.

Authors:  Ee Teng Goh; Caroline S Stokes; Sandeep S Sidhu; Hendrik Vilstrup; Lise Lotte Gluud; Marsha Y Morgan
Journal:  Cochrane Database Syst Rev       Date:  2018-05-15

10.  Repeated Measures of Blood and Breath Ammonia in Response to Control, Moderate and High Protein Dose in Healthy Men.

Authors:  Lisa A Spacek; Arthur Strzepka; Saurabh Saha; Jonathan Kotula; Jeffrey Gelb; Sarah Guilmain; Terence Risby; Steven F Solga
Journal:  Sci Rep       Date:  2018-02-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.